Lou Yu Yan

Director/Board Member presso ESLITE SPECTRUM CORPORATION

Finance

Communications

Electronic Technology

Profilo

Lou Yu Yan currently works at Qisda Corp., as Independent Director from 2020, Sinyi Realty, Inc., as Independent Director from 2017, ANZ Banking Corp., as Independent Director, and The Eslite Spectrum Corp., as Independent Director.
Mr. Yan also formerly worked at Chunghwa Telecom Co., Ltd., as Independent Director and Crown Bioscience International, as Independent Director.
Mr. Yan received his graduate degree from National Chengchi University.

Posizioni attive di Lou Yu Yan

Società	Posizione	Inizio
ESLITE SPECTRUM CORPORATION	Director/Board Member	-
SINYI REALTY INC.	Director/Board Member	26/05/2017
QISDA CORPORATION	Director/Board Member	19/06/2020
ANZ Banking Corp. ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia.	Director/Board Member	-

Tutte le posizioni attive di Lou Yu Yan

Precedenti posizioni note di Lou Yu Yan

Società	Posizione	Fine
CHUNGHWA TELECOM CO., LTD.	Director/Board Member	-
CROWN BIOSCIENCE INTERNATIONAL	Director/Board Member	-

Vedi nel dettaglio l'esperienza di Lou Yu Yan

Formazione di Lou Yu Yan

National Chengchi University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Lou Yu Yan

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
CHUNGHWA TELECOM CO., LTD.	Communications
QISDA CORPORATION	Electronic Technology
SINYI REALTY INC.	Finance
ESLITE SPECTRUM CORPORATION	Finance

Aziende private	2
ANZ Banking Corp. ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia.	Finance
Crown Bioscience International Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan.	Health Technology